InsidersTradesSigma
Track the HUM stock price and the full directors' dealings record of the company, a listed issuer based in Australia. Shares are quoted on the AU market, under the authority of ASX. Operating in the Healthcare & Pharma sector, HUM has logged 4 public disclosures. Market capitalisation: €232.3m. The latest transaction was filed on 14 May 2026 (Other). Among the most active insiders: substantial holder on 13 / 05 / 2026. The full history is free.
4
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 11,381 of 29,063 companies
57.0
score / 100
Value71
Quality44
FCF yld32%
Earn yld7.2%
EV/EBITDA14.7x
ROE3.0%
Gross mgn96%
Net mgn2.5%
Debt/EBITDA14.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 14 May 2026
Declarations4 total
ShareASXASX:2924-03090173-2A1672112
ShareASXASX:2924-03090172-2A1672111
ShareASXASX:2924-03090146-2A1672095
ShareASXASX:2924-03090145-2A1672094
4 of 4 declarations
Acerca de HUM
HUM es una empresa que opera en el sector de la salud y farmacéutico, cotizada en el mercado XASX. Se enfoca en el desarrollo y comercialización de soluciones innovadoras para mejorar la salud del paciente.
